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Gastrointestinal Tract Cancer. Eds. M.
LIPKIN and R. A. GoOD (1978). Sloan
Kettering Institute Cancer Series. New
York: Plenum Medical Book Co. 763 pp.
f28.35.
This is a splendid book. It provides an
excellent collection ofarticles on a number of
carefully selected topics on gastrointestinal
cancer. Most contributors are members of
staff of the Sloan Kettering Institute, New
York, butwellknownauthoritiesfromEurope
and the Far East arerepresented. The editors
are to be congratulated, not only on their
choice of expert contributors and their sub-
jects, but on producing a volume with a
remarkably uniform literary style. As a
result, it provides both profitable and enjoy-
ablereading.
There are substantial articles on the rela-
tionship of the immune system to gastro-
intestinal cancer, and an authoritative review
of ot chain disease as it affects the gut. The
absence of consideration of lymphomas of
the gastrointestinal tract is a surprising and
perhaps unfortunate omission. The epi-
demiology ofthese diseases is described in an
exemplary manner, at any rate for the under-
standing and interest of the clinician. The
importance of hereditary factors is well
defined, including an authoritative review of
familial polyposis coli.
Thereis also a mostuseful section onexperi-
mental carcinogenesis, animal systems and
models, which will be ofinterest to clinicians,
pathologists and others, as well as to research
workers. The use of carcino-embryonic anti-
gen is discussed in a detailed and critical man-
ner,indicating how it may besensibly used to
monitor the progress ofpatients with gastro-
intestinal cancer. There is a most exhaustive
review of skin markers of malignant disegse,
which will be ofgreat value to all oncologists
and dermatologists, as well as to gastro-
enterologists.
The weakest section of this book concerns
management of these diseases, and perhaps
this is a fair indication of our lack ofprogress
in this field. Advances elsewhere in our under-
standing ofgastrointestinal cancer have been
much more impressive. The discussion of
surgery, chemotherapy and immunotherapy
is much less perceptive than other contribu-
tions, but this does not detract from the
overall high standing ofthis book. It is to be
recommended to all oncologists, as well as to
physicians and surgeons interested in gastro-
enterology. It will be found to be a most
readable text, but it will also be a valuable
and stimulating source of reference to our
current understanding of origin, natural
history and management of gastrointestinal
cancer. It is a considerable contribution to the
literature on the subject.
W. IDUNCAN
The Story of Cancer. A. C. BRAUN (1979).
London: Addison-Wesley. pp. 308. E12.35
(HB). E6.05 (PB).
Before anyone has the temerity to write
or publish a book with such a bold title as
"The Story of Cancer", he should weigh the
prospect of the acclamation he might receive
from non-specialists against the likelihood of
his earning scathin comments from special-
ists and ultra specialists. Let me say at the
outset, therefore, that in my opinion the
decision to produce this book was right. It is
based on 4 lectures presented in 1977 at The
Rockefeller University in New York to a
select group of gifted high-school students,
and is intended to provide an overview ofthe
nature of cancer, its causes, treatments and
cures. Several other books which have
attempted to cover the same broad field have
suffered the disadvantage of multi-author-
ship. By contrast the present book, with its
continuity and freedom from overlap, is
refreshing to read. But perhaps its greatest
virtue is its clarity. The English style is
remarkablysimple in view ofthecomplexities
of the topics which are discussed. Moreover,
although reference is made to nearly 300
original papers, the text is not overburdened
in consequence.
MuchofBraun's ownresearchhasconcerned
planttumours,particularlycrown-galldisease.
Notsurprisingly, therefore, manyparts ofthe
text and most ofthe illustrations are devoted
to these subjects, and thesehighlyspecialized
parts ofthe cancer story are well-indexed. By
contrast, I looked in vain in the index for any
mention of Sir MacFarlane Burnet, immuno-
surveillance, orimmuno-therapy, eventhough
9 pages ofthe text are devoted to a clear and
useful discussion of "Immunological Ap-
proaches to Control". This illustrates the fact
that the book is much more vulnerable to
criticism in relation to what it does not con-
tain, thaninrelation to its contents. For those